Watch MBOT. Know when insiders buy.
One email the day a filing lands. Free.
MBOT
Microbot Medical Inc.
1.36
−0.06 −4.23%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
48
WATCH · shorts 48
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $91.3MP/E —DIV YIELD —FCF YIELD -19.63%REV TTM —NET INCOME −$16.3MNET CASH $3.1M52W 1.36 – 3.48SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $241K | — | -266.8% | −$6.2M | −$5.6M | — | -0.08 | −$5M | $142K | −$5.1M | Aug 11 |
| Q1 2026 · Mar 31 | $105K | — | 1.9% | −$4.3M | −$3.7M | — | -0.05 | −$5.1M | $108K | −$5.2M | Aug 11 |
| Q4 2025 · Dec 31derived | — | — | — | −$4.1M | −$3.5M | — | -0.04 | −$3.8M | $25K | −$3.8M | Mar 26 |
| Q3 2025 · Sep 30 | — | — | — | −$3.9M | −$3.6M | — | -0.07 | −$3.8M | $13K | −$3.9M | Nov 12 |
| Q2 2025 · Jun 30 | — | — | — | −$3.7M | −$3.5M | — | -0.10 | −$2.6M | $9K | −$2.6M | Aug 11 |
| Q1 2025 · Mar 31 | — | — | — | −$3M | −$2.6M | — | -0.08 | −$2.9M | $13K | −$2.9M | Aug 11 |
| Q4 2024 · Dec 31derived | — | — | — | −$3.4M | −$3.4M | — | -0.20 | −$1.7M | $7K | −$1.7M | Mar 26 |
| Q3 2024 · Sep 30 | — | — | — | −$3.3M | −$3.2M | — | -0.20 | −$2.8M | $0 | −$2.8M | Nov 12 |
| Q2 2024 · Jun 30 | — | — | — | −$2.5M | −$2.5M | — | -0.17 | −$2M | $4K | −$2M | Nov 12 |
| Q1 2024 · Mar 31 | — | — | — | −$2.4M | −$2.4M | — | -0.17 | −$2.4M | $14K | −$2.4M | Nov 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$2.1M | −$3.2M | — | -0.26 | −$1.8M | −$5K | −$1.8M | Mar 25 |
| Q3 2023 · Sep 30 | — | — | — | −$2.5M | −$2.4M | — | -0.21 | −$1.7M | $28K | −$1.7M | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$14.7M | −$13.1M | — | -0.29 | −$13M | $60K | −$13.1M | — | — |
| FY2024 · to Dec 31 | — | — | −$11.6M | −$11.4M | — | -0.73 | −$8.8M | $25K | −$8.9M | — | — |
| FY2023 · to Dec 31 | — | — | −$9.9M | −$10.7M | — | -1.05 | −$8.5M | $33K | −$8.6M | — | — |
| FY2022 · to Dec 31 | — | — | −$13.3M | −$13.2M | — | -1.81 | −$11.5M | $84K | −$11.6M | — | — |
| FY2021 · to Dec 31 | — | — | −$11.4M | −$11.3M | — | -1.59 | −$9.4M | $69K | −$9.4M | — | — |
| FY2020 · to Dec 31 | — | — | −$9.1M | −$9.2M | — | -1.29 | −$7.3M | $91K | −$7.3M | — | — |
Every number comes from Microbot Medical Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.